Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
deals
fda
life sciences
national blog main
national top stories
new york
2
×
new york blog main
2
×
new york top stories
novartis
2
×
achromatopsia
alirocumab
alnylam pharmaceuticals
amgen
beta-thalassemia
bill cassidy
biotech
bluebird bio
dna
evolocumab
gene therapy
harvard pilgrim health care
hemophilia
inclisiran
johnson & johnson
luxturna
mark warner
mathai mammen
medicaid
meiragtx
patient affordability value and efficiency act
pcsk9
pcsk9 inhibitors
regeneron pharmaceuticals
rna interference
sanofi
spark therapeutics
spinal muscular atrophy
What
deal
acquire
age
agreed
bigger
biggest
billion
brings
cash
cholesterol
come
company
compound
drug
emerging
fda
gave
gene
j
johnson
medco
medicines
meiragtx
morning
new
novartis
past
poised
ready
signal
signals
therapy
wave
years
Language
unset
Current search:
novartis
×
" new york blog main "
×
" new york "
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy